Refine by
Therapy Development Articles & Analysis: Older
559 news found
CD Bioparticles, a leading manufacturer and supplier of numerous drug delivery products and services, has announced the launch of its new Tumor Organoid & CAF Co-culture services to provide researchers with a more physiologically relevant in vitro tumor model, enabling a deeper understanding of tumor-stromal interactions and the development of more effective cancer ...
These rigorously validated antigens are suitable for use in HBV mimetics, standard antigens for ELISA, and Western blotting, and are designed to assist researchers in advancing their understanding of HBV infection and developing novel diagnostic methods or more effective antiviral therapies. ...
” She emphasized that understanding these metabolic processes not only aids in identifying biomarkers for diseases but also helps in the development of targeted therapies and optimization of bioproduction processes. ...
In dermatology, new methods for treating benign epidermal lesions are emerging, alongside the development of drug-free therapies to enhance patient well-being. Surgical innovations, such as advanced transplant surgery instruments and bone cement applications, are optimizing complex procedures. Additionally, exosome-loaded protein-based therapy ...
In many research applications, such as gene expression studies, vaccine development, and gene therapy, transfection—the process of introducing nucleic acids into cells—is an essential step. ...
With the advancement of biotechnology and biological tools, such as diagnostic technology and animal model development, researchers can further investigate the mechanisms related to depression and thereby develop effective therapies targeting depression. Ace Therapeutics Psychiatry Team is committed to supporting scientists in making ...
Protheragen, a dedicated preclinical research service provider specializing in rare diseases, announces its comprehensive diagnostic development services aimed at empowering researchers in the realm of rare disease research and drug development. ...
By breaking down their diverse applications, this blog highlights the critical value of PCLS in addressing unmet needs in COPD research and therapy development. ...
Profacgen, a leading provider of custom biotechnology services, is pleased to announce significant updates to its Antimicrobial Peptides (AMPs) Services, enhancing its capabilities to support the growing demand for alternative therapies in the fight against drug-resistant pathogens. As antibiotic resistance continues to pose a global health threat, Profacgen is expanding its ...
As of the latest research, several experimental gene therapies for glaucoma are in various stages of development, from preclinical studies to early-phase clinical trials. ...
Recent years have witnessed the development of a series of disease models for cardiovascular disease research, such as cardiac organoid models and cardiomyocyte models, which greatly contribute to the basic research on the pathogenic mechanisms of various cardiovascular diseases and the development of new therapeutic methods. ...
In the rapidly evolving landscape of pharmaceutical innovations, CD Formulation emerges as a key player, offering customized drug conjugates services that cater to the rising demands for advanced drug development. Specializing in complex biologic formulations, Biologics & Biosimilars service team of CD Formulation is revolutionizing how drug conjugate products are ...
CD BioSciences, a US-based biotechnology company focusing on the development of imaging technologies, is excited to announce the launch of its new Immune System Tissue Microarrays for the scientific community to study the complex interactions of the immune system in various tissues. These innovative products offer researchers a powerful tool to unravel the complexities of the ...
Our product offerings include: Cholesterol (Plant-Derived) (CAS NO.: 57-88-5) DSPE (CAS NO.: 1069-79-0) mPEG-DSPE DSPE-PEG-NH2 DSPE-PEG-Mannose DSPE-PEG-Mal And many more… These specialized materials are crucial for improving the stability, efficacy, and overall functionality of LNPs. By facilitating the development of cutting-edge therapies, our products ...
With extensive experience in the antipsychiatry industry, the Ace Therapeutics Psychiatry team understands the unique challenges and complexities of developing effective therapies for psychiatric disorders. By leveraging its expertise and resources, the company can develop animal models, cell models, multicellular models, ...
As cancer cases continue to rise across the globe, our understanding of the disease becomes more nuanced. Newer, more effective therapies are being developed each day, and data is becoming increasingly critical in diagnosis, therapy selection, and drug development. ...
Therefore, there is a need for the development of new drug delivery systems for glaucoma to address these shortcomings. As a CRO company with a wide range of services in basic research, drug development, and preclinical studies, Ace Therapeutics can assist researchers in developing convenient, safe, and effective sustained-release drug delivery ...
Following with the announcement of developing small molecule drug for glaucoma, Ace Therapeutics recently unveiled disease model customization services to accelerate further the preclinical research on gastroenterology (GI) and hepatology. ...
The company’s vaccine development capabilities span delivery system development, assay development, and animal model development. ...
Remarkably, BOC Sciences can provide tailored exosomes filled with siRNA, which has led to several successful cases in the development of gene therapies and innovative drug delivery systems. Initially, BOC Sciences creates and synthesizes siRNA that targets specific genes, and then incorporates them into the exosomes. ...